tiprankstipranks
Bluebird bio Reports Q3 2024 Earnings and Future Outlook
PremiumCompany AnnouncementsBluebird bio Reports Q3 2024 Earnings and Future Outlook
6d ago
Bluebird Bio reports Q3 EPS (31c), consensus (35c)
Premium
The Fly
Bluebird Bio reports Q3 EPS (31c), consensus (35c)
7d ago
Bluebird Bio’s Key Decisions and Shareholder Engagement in 2024
Premium
Company Announcements
Bluebird Bio’s Key Decisions and Shareholder Engagement in 2024
14d ago
Leerink sees little impact to genetic medicines from Pfizer’s Oxbryta withdrawal
PremiumThe FlyLeerink sees little impact to genetic medicines from Pfizer’s Oxbryta withdrawal
2M ago
Bluebird Bio price target lowered to $2 from $3 at Wells Fargo
Premium
The Fly
Bluebird Bio price target lowered to $2 from $3 at Wells Fargo
2M ago
Bluebird Bio Announces Restructuring and Targets Break-Even
Premium
Company Announcements
Bluebird Bio Announces Restructuring and Targets Break-Even
2M ago
Bluebird Bio price target lowered to $6 from $7 at Baird
PremiumThe FlyBluebird Bio price target lowered to $6 from $7 at Baird
3M ago
Bluebird Bio price target lowered to $4 from $8 at Barclays
Premium
The Fly
Bluebird Bio price target lowered to $4 from $8 at Barclays
3M ago
Bluebird Bio downgraded to Neutral from Overweight at JPMorgan
Premium
The Fly
Bluebird Bio downgraded to Neutral from Overweight at JPMorgan
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100